|
Reuters) - Benefits from rotavirus vaccines made by GlaxoSmithKline Plc and Merck & Co Inc outweigh any risk from recently discovered contamination with a pig virus, members of a U.S. advisory panel said on Friday. |
|
Monday, 10 May 2010 00:00 |
|
Click here to read more
|